Earnings estimate revision

搜索文档
Wall Street Analysts Predict a 26.72% Upside in Gentherm (THRM): Here's What You Should Know
ZACKS· 2025-08-01 22:56
Gentherm (THRM) closed the last trading session at $32.04, gaining 4.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $40.6 indicates a 26.7% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $6.91. While the lowest estimate of $35.00 indicates a 9.2% increase from the current price level, the most optimistic analyst expects t ...
Wall Street Analysts Think Amneal (AMRX) Could Surge 43.82%: Read This Before Placing a Bet
ZACKS· 2025-07-29 22:56
Amneal Pharmaceuticals (AMRX) closed the last trading session at $8.17, gaining 1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $11.75 indicates a 43.8% upside potential.The average comprises four short-term price targets ranging from a low of $11.00 to a high of $12.00, with a standard deviation of $0.5. While the lowest estimate indicates an increase of 34.6% from the current ...
Exploring Analyst Estimates for Reinsurance Group (RGA) Q2 Earnings, Beyond Revenue and EPS
ZACKS· 2025-07-29 13:06
核心观点 - 华尔街分析师预测再保险集团(RGA)即将发布的季度每股收益为5.58美元,同比增长1.8%,营收预计为57.1亿美元,同比增长10.8% [1] - 过去30天内,分析师对季度每股收益的共识预期下调了0.3%,显示分析师对初始预测的重新评估 [2] - 分析师对关键指标的预测显示,不同业务板块的税前调整后经营收入呈现差异化表现,其中亚太地区传统业务预计同比增长1.2%,而美国及拉丁美洲传统业务预计同比下降22.4% [6][7][8][10] 财务预测 - 净保费收入预计为43.2亿美元,同比增长10.2%,其他收入预计为1.0995亿美元,同比下降25.2% [5] - 亚太地区税前调整后经营收入预计为1.7126亿美元,同比微增0.7%,加拿大地区预计为4630万美元,同比增长40.3% [6] - 美国及拉丁美洲地区税前调整后经营收入预计为2.0558亿美元,同比下降16.8%,欧洲、中东和非洲地区预计为1.1204亿美元,同比增长31.8% [7] 业务细分表现 - 亚太地区传统业务税前调整后经营收入预计为1.0019亿美元,同比增长1.2%,金融解决方案业务预计为6882万美元,同比下降3.1% [8] - 美国及拉丁美洲金融解决方案业务预计为7648万美元,同比下降4.4%,加拿大金融解决方案业务预计为841万美元,同比增长20.1% [9] - 加拿大传统业务预计为3833万美元,同比增长47.4%,美国及拉丁美洲传统业务预计为1.2963亿美元,同比下降22.4% [10] 市场表现 - 再保险集团股价在过去一个月下跌0.5%,同期标普500指数上涨4.9%,公司Zacks评级为3(持有),预计未来表现与整体市场一致 [11]
What Analyst Projections for Key Metrics Reveal About Commvault (CVLT) Q1 Earnings
ZACKS· 2025-07-24 22:16
Wall Street analysts expect Commvault Systems (CVLT) to post quarterly earnings of $0.97 per share in its upcoming report, which indicates a year-over-year increase of 14.1%. Revenues are expected to be $268.67 million, up 19.6% from the year-ago quarter.The current level reflects an upward revision of 0.7% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Ahead o ...
Unlocking Q2 Potential of Ecolab (ECL): Exploring Wall Street Estimates for Key Metrics
ZACKS· 2025-07-24 22:16
The upcoming report from Ecolab (ECL) is expected to reveal quarterly earnings of $1.90 per share, indicating an increase of 13.1% compared to the year-ago period. Analysts forecast revenues of $4.01 billion, representing an increase of 0.6% year over year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Prior to a company's earnings announceme ...
Starbucks (SBUX) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
ZACKS· 2025-07-24 22:16
In its upcoming report, Starbucks (SBUX) is predicted by Wall Street analysts to post quarterly earnings of $0.64 per share, reflecting a decline of 31.2% compared to the same period last year. Revenues are forecasted to be $9.29 billion, representing a year-over-year increase of 1.9%.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 2.7% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during th ...
Gear Up for Universal Health Services (UHS) Q2 Earnings: Wall Street Estimates for Key Metrics
ZACKS· 2025-07-23 22:16
The upcoming report from Universal Health Services (UHS) is expected to reveal quarterly earnings of $4.85 per share, indicating an increase of 12.5% compared to the year-ago period. Analysts forecast revenues of $4.22 billion, representing an increase of 8% year over year. Analysts expect 'Net Revenues- Behavioral health services' to come in at $1.86 billion. The estimate indicates a year-over-year change of +7.4%. The consensus among analysts is that 'Admissions - Behavioral health' will reach 122,616 . C ...
What Analyst Projections for Key Metrics Reveal About Cadence (CDNS) Q2 Earnings
ZACKS· 2025-07-23 22:16
Wall Street analysts forecast that Cadence Design Systems (CDNS) will report quarterly earnings of $1.57 per share in its upcoming release, pointing to a year-over-year increase of 22.7%. It is anticipated that revenues will amount to $1.26 billion, exhibiting an increase of 18.7% compared to the year-ago quarter. Analysts expect 'Revenue- Product and maintenance' to come in at $1.15 billion. The estimate points to a change of +19.6% from the year-ago quarter. The collective assessment of analysts points to ...
Group 1 Automotive (GPI) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
ZACKS· 2025-07-23 22:16
核心财务预测 - 华尔街分析师预测Group 1 Automotive季度每股收益为10.31美元 同比增长5.2% [1] - 预计季度营收达55.5亿美元 同比增长18.2% [1] - 过去30天内共识EPS预期上调0.4% 反映分析师对初始估计的重新评估 [2] 收入细分预测 - 新车零售收入预计27.8亿美元 同比增长17.8% [5] - 金融保险及其他净收入预计2.2158亿美元 同比增长10.7% [5] - 二手车总收入预计18.2亿美元 同比增长16.8% [5] - 二手车批发收入预计1.238亿美元 同比增长18.7% [6] 区域市场表现 - 美国市场新车零售收入预计22亿美元 同比增长9.4% [6] - 美国市场二手车零售收入预计12.1亿美元 同比增长4.7% [6] - 英国市场新车零售收入预计5.8926亿美元 同比大幅增长66.2% [7] - 英国市场金融保险净收入预计2495万美元 同比增长53.1% [7] 销售数量指标 - 零售新车销量预计55,942辆 对比去年同期47,661辆 [8] - 零售二手车销量预计56,854辆 对比去年同期49,260辆 [8] - 英国零售新车销量预计14,037辆 对比去年同期8,388辆 [9] 单价指标 - 美国二手车零售平均单价预计30,182.89美元 对比去年同期29,834美元 [9]
Wall Street Analysts See a 39.97% Upside in Genmab (GMAB): Can the Stock Really Move This High?
ZACKS· 2025-07-22 22:55
股价表现与目标价分析 - Genmab ADR(GMAB)最新收盘价为21 69美元 过去四周累计上涨4 9% 华尔街分析师给出的平均目标价30 36美元隐含40%上行空间 [1] - 7位分析师目标价区间为20-46美元 标准差8 82美元 最低目标价隐含7 8%跌幅 最高目标价隐含112 1%涨幅 标准差反映分析师预测分歧程度 [2] - 尽管共识目标价受投资者关注 但单纯依赖该指标可能产生误导 分析师设定目标价的能力和客观性长期受质疑 [3] 盈利预测修正 - 分析师对公司盈利前景的乐观情绪增强 当前年度Zacks共识盈利预测过去30天上调7 4% 其中2位上调1位下调 [12] - 盈利预测修正趋势与短期股价走势存在强相关性 分析师对EPS预测上修的一致性强化了股价上行预期 [4][11] - GMAB目前获Zacks排名第一(强力买入) 位列4000多只股票前5% 该排名基于盈利预测相关的四项因素 具有较高参考价值 [13] 目标价有效性分析 - 全球多所大学研究表明 分析师目标价误导投资者的频率高于指导作用 实证显示目标价很少能准确预测股价实际走向 [7] - 华尔街分析师虽掌握公司基本面 但常因商业利益(如维护客户关系)设定过度乐观目标价 导致目标价虚高 [8] - 低标准差显示分析师对股价变动方向和幅度高度一致 虽不能保证达到平均目标价 但可作为研究潜在驱动力的起点 [9] 投资决策建议 - 投资者不应完全忽视目标价 但仅凭此决策可能导致投资回报不及预期 需保持高度审慎态度 [10] - 对GMAB而言 共识目标价虽不能可靠预测涨幅 但其暗示的价格方向仍具参考价值 结合盈利预测修正趋势更具指导意义 [14]